Cellular prion protein: A co-receptor mediating neuronal cofilin-actin rod formation induced by β-amyloid and proinflammatory cytokines

Prion

Volumn 8, Issue 6, 2014, Pages 375-380

  Walsh, Keifer P ^a   Kuhn, Thomas B ^b   Bamburg, James R ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

^b UNIVERSITY OF ALASKA FAIRBANKS   (United States)

Author keywords

Actin; Alzheimer disease; Caveolin 1; Cellular prion protein; Cofilin; Lipid rafts; NADPH oxidase; Oxidative stress; Proinflammatory cytokines

Indexed keywords

AMYLOID BETA PROTEIN; CELL PROTEIN; CELLULAR PRION PROTEIN; COFILIN; CYTOKINE; PRION PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG; CFL1 PROTEIN, MOUSE; COFILIN 1; EPITOPE; PRION;

ACTIN FILAMENT; CELL MEMBRANE; COGNITION; COGNITIVE DEFECT; CONFORMATIONAL TRANSITION; DEGENERATIVE DISEASE; ENZYME ACTIVATION; NERVE CELL; NERVE CELL PLASTICITY; NERVOUS SYSTEM INFLAMMATION; NEURITE; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; TRAUMATIC BRAIN INJURY; ALZHEIMER DISEASE; ANIMAL; BRAIN; CHEMISTRY; CYTOSKELETON; DISEASE MODEL; INFLAMMATION; METABOLISM; MOUSE; PATHOLOGY; PRION; PROTEIN TERTIARY STRUCTURE; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; CELL MEMBRANE; COFILIN 1; CYTOSKELETON; DISEASE MODELS, ANIMAL; EPITOPES; INFLAMMATION; MICE; MICE, TRANSGENIC; NADPH OXIDASE; NEURODEGENERATIVE DISEASES; NEURONS; PRIONS; PROTEIN STRUCTURE, TERTIARY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84920933321     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.35504     Document Type: Review

References (40)

1. Jackson GS, Murray I, Hosszu LL, Gibbs N, Waltho JP, Clarke AR, Collinge J. Location and properties of metal-binding sites on the human prion protein. Proc Natl Acad Sci 2001; 98:8531-5; PMID:11438695; http://dx.doi.org/10.1073/pnas.151038498
2. Hernandez-Rapp J, Martin-Lannerée S, Hirsch TZ, Launay JM, Mouillet-Richard S. Hijacking PrPC-dependent signal transduction: when prions impair Aβ clearance. Front Aging Neurosci 2014; 6:25-30; PMID:24592237; http://dx.doi.org/10.3389/fnagi.2014.00025
3. Ermonval M, Mouillet-Richard S, Codogno P, Kellermann O, Botti J. Evolving views in prion glycosylation: functional and pathological implications. Biochimie 2003; 85:33-45; PMID:12765773; http://dx.doi.org/10.1016/S0300-9084(03)00040-3
4. Prusiner SB. Biology and genetics of prions causing neurodegeneration. Annu Rev Genet 2013; 47:601-23; PMID:24274755; http://dx.doi.org/10.1146/annurev-genet-110711-155524
5. Renner M, Melki R. Protein aggregation and prionopathies. Pathol Biol 2014; S0369-8114: 33-9
6. Barmada S, Piccardo P, Yamaguchi K, Ghetti B, Harris DA. GFP-tagged prion protein is correctly localized and functionally active in the brains of transgenic mice. Neurobiol Dis 2004; 16:527-37; PMID:15262264; http://dx.doi.org/10.1016/j.nbd.2004.05.005
7. Um JW, Strittmatter SM. Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease. Prion 2013; 7:37-41; PMID:22987042; http://dx.doi.org/10.4161/pri.22212
8. Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM, Kellermann O. Signal transduction through prion protein. Science 2000; 289:1925-8; PMID:10988071; http://dx.doi.org/10.1126/science.289.5486.1925
9. Haughey NJ, Veera VR, Mihyun B, Mattson MP. Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis. Biochim Biophys Acta 2010; 1801:878-86; PMID:20452460; http://dx.doi.org/10.1016/j.bbalip.2010.05.003
10. Fantini J, Barrantes FJ. Sphingolipidcholesterol regulation of neurotransmitter receptor conformation and function. Biochim Biophys Acta 2009; 1788:2345-61; PMID: 19733149; http://dx.doi.org/10.1016/j.bbamem.2009.08.016
11. Michel V., Bakovic M. Lipid rafts in health and disease. Bio Cell 2007; 99:129-40; PMID:17064251; http://dx.doi.org/10.1042/BC20060051
12. Sultana R, Perluigi M, Butterfield DA. Lipid peroxidation triggers neurodegeneration: a redox proteomics view into Alzheimer disease brain. Free Radic Biol Med 2013; 62:157-69; PMID:23044265; http://dx.doi.org/10.1016/j.freeradbiomed.2012.09.027
13. Taylor DR, Hooper NM. The prion protein and lipid rafts. Mol Memb Biol 2006; 31:89-99; PMID:16611584; http://dx.doi.org/10.1080/09687860500449994
14. Sanghera N, Correia BEFS, Correia JRS, Ludwig C, Agarwal S, Nakamura HK, Kuwata K, Samain E, Gill AC, Bonev BB, et al. Deciphering the molecular details for the binding of the prion protein to main ganglioside GM1 of neuronal membranes. Chem Biol 2011; 18:1422-31; PMID:22118676; http://dx.doi.org/10.1016/j.chembiol.2011.08.016
15. Pradines E, Hernandez-Rapp J, Villa-Diaz A, Dakowski C, Ardila-Osorio H, Haik S, Schneider B, Launay LM, Kellerman O, Torres JM, et al. Pathogenic prions deviate PrPC signaling in neuronal cells and impair A-beta clearance. Cell Death Dis 2013; 4:e456; PMID:23303130; http://dx.doi.org/10.1038/cddis.2012.195
16. Masters CL, Selkoe DJ. Biochemistry of Amyloid β-protein and amyloid deposits in Alzheimer disease. Cold Spring Harb Perspect Med 2012; 2:a006262; PMID: 22675658; http://dx.doi.org/10.1101/cshperspect.a006262
17. McDonald JM, Cairns NJ, Taylor-Reinwald L, Holtzman D, Walsh DM. The levels of water-soluble and triton-soluble Aβ are increased in Alzheimer's disease brain. Brain Res 2012; 1450:138-47; PMID:22440675; http://dx.doi.org/10.1016/j.brainres.2012.02.041
18. Chung E, Ji Y, Sun Y, Kascsak RJ, Kascsak RB, Mehta PD, Strittmatter SM, Wisniewski T. Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse. BMC Neurosci 2010; 11:130-40; PMID:20946660; http://dx.doi.org/10.1186/1471-2202-11-130
19. Lin Y, Wen L. Inflammatory response following diffuse axonal injury. Int J Med Sci 2013; 10:515-21; PMID:23532682; http://dx.doi.org/10.7150/ijms.5423
20. Yang B, Rizzo V. TNF-alpha potentiates protein-tyrosine nitration through activation of NADPH oxidase and eNOS localized in membrane rafts and caveolae of bovine aortic endothelial cells. Am J Physiol Heart Circ Physiol 2007; 292:H954-62; PMID:17028163; http://dx.doi.org/10.1152/ajpheart.00758.2006
21. Barth BM, Gustafson SJ, Hankins JL, Kaiser JM, Haakenson JK, Kester M, Kuhn TB. Ceramide kinase regulates TNFα-stimulated NADPH oxidase activity and eicosanoid biosynthesis in neuroblastoma cells. Cell Signal 2012; 24:1126-33; PMID:22230689; http://dx.doi.org/10.1016/j.cellsig.2011.12.020
22. Bernstein BW, Shaw AE, Minamide LS, Pak CW, Bamburg JR. Incorporation of cofilin into rods depends on disulfide intermolecular bonds: implications for actin regulation in neurodegenerative disease. J Neurosci 2012; 32:6670-81; PMID:22573689; http://dx.doi.org/10.1523/JNEUROSCI.6020-11.2012
23. Minamide LS, Striegl AM, Boyle JA, Meberg PF, Bamburg JR. Neurodegenerative stimuli induce persistent ADFcofilin-actin rods that disrupt distal neurite function. Nat Cell Biol 2000; 2: 628-36; PMID:10980704; http://dx.doi.org/10.1038/35023579
24. Maloney MT, Minamide LS, Kinley AW, Boyle JA, Bamburg JR. Beta-secretase-cleaved amyloid precursor proteins accumulates at actin inclusions induced in neurons by stress or amyloid beta: a feedforward mechanism for Alzheimer's disease. J Neurosci 2005; 25: 11313-21; PMID:16339026; http://dx.doi.org/10.1523/JNEUROSCI.3711-05.2005
25. Schönhofen P, Marengo de Medeiros L, Chatain CP, Bristot IJ, Klamt F. Cofilinactin rod formation by dysregulation of cofilin-1 activity as a central step in neurodegeneration. Mini Rev Med Chem 2014; 14:393-400; PMID: 24813767; http://dx.doi.org/10.2174/1389557514666140506161458
26. Cichon J, Sun C, Chen B, Jiang M, Cheng XA, Sun Y, Wang Y, Chen G. Cofilin aggregation blocks intracellular trafficking and induces synaptic loss in hippocampal neurons. J Biol Chem 2012; 287:3919-29; PMID:22184127; http://dx.doi.org/10.1074/jbc.M111.301911
27. Mi J, Shaw AE, Pak CW, Walsh KP, Minamide LS, Bernstein BW, Kuhn TB, Bamburg JR. A genetically encoded reporter for real-time imaging of cofilin-actin rods in living neurons. PLoS One 2013; 8:e83609; PMID:24391794; http://dx.doi.org/10.1371/journal.pone.0083609
28. Thinakaran G, Koo EH. Amyloid precursor protein trafficking, processing, and function. J Biol Chem 2008; 283:29615-9; PMID:18650430; http://dx.doi.org/10.1074/jbc.R800019200
29. Wolf M, Zimmermann AM, Gorlich A, Gurniak CB, Sassoe-Pognetto M, Friauf E, Witke W, Rust MB. ADF/cofilin controls synaptic actin dynamics and regulates vesicle mobilization and exocytosis. Cereb Cortex 2014; PMID:24770705
30. Davis RC, Marsden IT, Maloney MT, Minamide LS, Podlisny M, Selkoe DJ, Bamburg JR. Amyloid beta dimerstrimers potently induce cofilin-actin rods that are inhibited by maintaining cofilin phosphorylation. Mol Neurodegen 2011; 6:10; http://dx.doi.org/10.1186/1750-1326-6-10
31. Walsh KP, Minamide LS, Kane SJ, Shaw AE, Brown DR, Pulford B, Zabel MD, Lambeth JD, Kuhn TB, Bamburg JR. Amyloid-β and proinflammatory cytokines utilize a prion protein-dependent pathway to activate NADPH oxidase and induce cofilin-actin rods in hippocampal neurons. PLoS One 2014; 9:e95995; PMID:24760020; http://dx.doi.org/10.1371/journal.pone.0095995
32. Bate C, Williams A. Clustering of sialylated glycosylphosphatidylinositol anchors mediates PrP-induced activation of cytoplasmic phospholipase A2 and synapse damage. Prion 2012; 6:350-3; PMID:22895089; http://dx.doi.org/10.4161/pri.21751
33. Clarke CJ, Wu BX, Hannun YA. The neutral sphingomyelinase family: identifying biochemical connections. Adv Enzyme Regul 2011; 51:51-8; PMID:21035485; http://dx.doi.org/10.1016/j.advenzreg.2010.09.016
34. Shi Q, Jing YY, Wang SB, Chen C, Sun H, Xu Y, Gao C, Zhang J, Tian C, Guo Y, et al. PrP octarepeats region determined the interaction with caveolin-1 and phosphorylation of caveolin-1 and fyn. Med Microbiol Immunol 2013; 202:215-27; PMID:23283514; http://dx.doi.org/10.1007/s00430-012-0284-8
35. Huang TY, Minamide LS, Bamburg JR, Bokoch GM. Chronophinmediates an ATP-sensingmechanism for cofilin dephosphorylation and neuronal cofilin-actin rod formation. Dev Cell 2008; 15:691-703; PMID:19000834; http://dx.doi.org/10.1016/j.devcel.2008.09.017
36. Hernandez F, Avila J. Tauopathies. Cell Mol Life Sci 2007; 64:2219-33; PMID:17604998; http://dx.doi.org/10.1007/s00018-007-7220-x
37. Scheff SW, Neltner JH, Nelson PT. Is synaptic loss a unique hallmark of Alzheimer's disease? Biochem Pharmacol 2014; 88:517-28; PMID:24412275; http://dx.doi.org/10.1016/j.bcp.2013.12.028
38. Schneider B, Mutel V, Pietri M, Ermoval M, Mouillet-Richard S, Kellermann O. NADPH oxidase and extracellular regulated kinases 12 are targets of prion protein signaling in neuronal and nonneuronal cells. Proc Natl Acad Sci 2003; 100:13326-31; PMID:14597699; http://dx.doi.org/10.1073/pnas.2235648100
39. Ansari MA, Scheff SW. NADPH-oxidase activation and cognition in Alzheimer disease progression. Free Radic Biol Med 2011; 51:171-8; PMID:21457777; http://dx.doi.org/10.1016/j.freeradbiomed.2011.03.025
40. Head BP, Patel HH, Insel PA. Interaction of membranelipid rafts with the cytoskeleton: Impact on signaling and function. Biochim Biophys Acta 2014; 1838:532-45; PMID:23899502; http://dx.doi.org/10.1016/j.bbamem.2013.07.018